Form D — Acurx Pharmaceuticals, Inc.
0001736243-25-000003 · filed 2025-05-20
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $12,000,000
- Total sold
- $0
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Acurx Pharmaceuticals, Inc.
- CIK
- 1736243
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 259 LIBERTY AVENUE
STATEN ISLAND, NY 10305 - Phone
- 917-533-1469
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
David P. Luci · Executive OfficerStaten Island, NY Find on LinkedIn ↗
-
Robert J. DeLuccia · Executive OfficerStaten Island, NY Find on LinkedIn ↗
-
Robert G. Shawah · Executive OfficerStaten Island, NY Find on LinkedIn ↗
-
Jack H. Dean · DirectorStaten Island, NY Find on LinkedIn ↗
-
James Donohue · DirectorStaten Island, NY Find on LinkedIn ↗
-
Thomas Harrison · DirectorStaten Island, NY Find on LinkedIn ↗
-
Carl Sailer · DirectorStaten Island, NY Find on LinkedIn ↗
-
Joseph Scodari · DirectorStaten Island, NY Find on LinkedIn ↗
View original on SEC EDGAR.